Ferring Pharmaceuticals, Inc.
Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour
- Conditions
- Labor InductionCervical Ripening
- Interventions
- First Posted Date
- 2006-06-30
- Last Posted Date
- 2012-06-18
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 124
- Registration Number
- NCT00346840
- Locations
- 🇬🇧
Northampton General Hospital, Northampton, United Kingdom
🇬🇧The Queen's Mother's Hospital, Yorkhill, Glasgow, United Kingdom
🇬🇧Liverpool Women's Hospital, Liverpool, United Kingdom
Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide
- First Posted Date
- 2006-05-25
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 182
- Registration Number
- NCT00329693
- Locations
- 🇪🇸
IVI Bilbao, Paseo Landabarri, 1, Leioa-Bizkaia, Spain
🇪🇸IVI Sevilla, Avda. República Argentina, 58, Sevilla, Spain
🇪🇸IVI Barcelona, Ronda General Mitre, 14, Barcelona, Spain
Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor
- Conditions
- Cervical RipeningLabor, Induced
- Interventions
- First Posted Date
- 2006-03-30
- Last Posted Date
- 2012-06-25
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 1308
- Registration Number
- NCT00308711
- Locations
- 🇺🇸
Trident Health System, North Charleston, South Carolina, United States
🇺🇸Methodist Charlton Medical Center, Dallas, Texas, United States
🇺🇸Ohio State University Medical Center, Columbus, Ohio, United States
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH
- Conditions
- InFertility
- Interventions
- Drug: Pulsatile gonadotropin-releasing hormone (GnRH)Drug: Placebo Pulsatile GnRH
- First Posted Date
- 2006-02-27
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 132
- Registration Number
- NCT00296465
- Locations
- 🇺🇸
Southern Fertility Center and Clinical Research, Metairie, Louisiana, United States
Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)
- First Posted Date
- 2006-02-27
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 1211
- Registration Number
- NCT00296478
The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer
- First Posted Date
- 2006-02-24
- Last Posted Date
- 2012-12-19
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 620
- Registration Number
- NCT00295750
- Locations
- 🇺🇸
Office of Jeffrey Frankel, Seattle, Washington, United States
🇺🇸Western Clinical Research, Torrance, California, United States
🇺🇸Regional Urology, Shreveport, Louisiana, United States
Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer
- First Posted Date
- 2005-12-23
- Last Posted Date
- 2010-12-24
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 278
- Registration Number
- NCT00268892
- Locations
- 🇫🇷
Fédération d'Urologie et Néphrologie, BP69 Hôpital Pasteur, Nice, France
🇧🇪UZ Gasthuisberg Leuven, Leuven, Belgium
🇩🇪Gemeinschaftspraxis Dres Effert und Benedic, Aachen, Germany
A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa
- First Posted Date
- 2005-11-23
- Last Posted Date
- 2010-02-26
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 80
- Registration Number
- NCT00257556
- Locations
- 🇬🇧
The Royal Hallamshire Hospital, University of Sheffield, Jessop Wing, Tree Root Walk, Sheffield, United Kingdom
🇬🇧Leeds General Infirmary, Great George Street, Leeds, United Kingdom
🇩🇪Gemeinschaftspraxis und Tagesklinik, Zingel 29, Hildesheim, Germany
An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG
- Conditions
- Turner's Syndrome
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2011-05-20
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 27
- Registration Number
- NCT00250250
- Locations
- 🇨🇿
Faculty Hospital Olomouc, Children's Clinic, Endocrinology Outpatient Department, I.P.Pavlova str. 6,, Olomouc, Czech Republic
🇫🇷Service de Pédiatrie, Groupe Hospitalier du Havre, 55 bis, rue Gustave Flaubert, Le Havre cedex, France
🇫🇷Centre d'Endocrinologie Pediatrique, 25 rue Boudet, Bordeaux, France
The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"
- Conditions
- Crohn's Disease
- First Posted Date
- 2005-10-28
- Last Posted Date
- 2012-03-12
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 3
- Registration Number
- NCT00245505
- Locations
- 🇸🇪
Department of Medicine, Malmö University Hospital, Malmo, Malmö, Sweden